期刊文献+

上皮钙黏着蛋白mRNA表达与肺癌的相关性研究

Research on correlation between E-cadherin mRNA expression and lung cancer
下载PDF
导出
摘要 目的探讨E-cadherin(上皮钙黏着蛋白,E-cad)mRNA与肺癌及其病理类型之间的相关性。方法用巢式RT-PCR检测50例肺癌患者的癌、癌旁和远癌肺组织及5例肺良性对照标本中的E-cad mRNA的相对表达量。结果癌组织1.33±0.53、癌旁组织1.65±0.60、远癌组织2.01±0.46、非肺癌对照肺组织2.09±0.09,经方差分析癌、癌旁和远癌组织差异有统计学意义(F=18.810,P<0.01),但远癌组织与非肺癌对照肺组织之间的差异无统计学意义(P>0.05)。肺鳞癌、腺癌及腺鳞癌的癌组织、癌旁组织和远癌组织中E-cad mRNA水平差异无统计学意义(P>0.05)。结论E-cad mRNA表达减少或缺失与肺癌的发生和发展有相关性,与肺癌的组织类型无关。 Objective To explore the correlation of E-cadherin (E-cad) mRNA expression with tumorigenesis and development of lung cancer. Methods The relative quantitative nested RT-PCR was used to detect the expression of E-cad mRNA in cancerous tissues, adjacent and distal tissues of tumor from 50 lung cancer patients, and non-cancerous benign lung tissues from 5 lung disorder patients. Re- sults The means of expression rate of E-cad mRNA in cancerous tissue, adjacent and distal tissues of tumor, and non-cancerous tissues were 1.33 ±0.53,1.65 ± 0.60, 2.01 ± 0.46 and 2.09± 0.09 respectively. The data were evaluated by analysis of variance. There were significant difference among cancerous tissue, adjacent and distal tissue ( F = 18. 810, P 〈 0.01 ), but there was no significant difference between distal tissues of lung cancer and non-cancerous lung tissues (P 〉 0.05 ). Also, there were no significant differences among squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma in the group of cancerous, adjacent and distal tissue. Conclusion The reduced expression of E-cadherin mRNA may play important role for tumorigenesis and development of lung cancer, and there was no evident relationship of E-cad mRNA with different pathological types of lung cancer.
出处 《临床检验杂志》 CAS CSCD 北大核心 2008年第5期339-341,共3页 Chinese Journal of Clinical Laboratory Science
关键词 肺癌 上皮钙黏着蛋白mRNA 巢式RT—PCR lung cancer E-cadherin mRNA nested RT-PCR
  • 相关文献

参考文献4

二级参考文献51

  • 1乔贵宾,吴一龙,区伟,杨学宁,钟文昭,林嘉颖,赵建,谢丹,关新元.免疫组化方法检测肿瘤标志在肺癌组织芯片中表达的可靠性研究[J].肿瘤防治研究,2004,31(8):467-470. 被引量:11
  • 2[1]Lagergren J.Adenocarcinoma of oesophagus:what exactly is the size of the problem and who is at risk? Gut 2005;54 Suppl 1:11-15
  • 3[2]Jankowski JA,Harrison RF,Perry I,Balkwill F,Tselepis C.Barrett's metaplasia.Lancet 2000;356:2079-2085
  • 4[3]Koppert LB,Wijnhoven BP,van Dekken H,Tilanus HW,Dinjens WN.The molecular biology of esophageal adenocarcinoma.J Surg Oncol 2005;92:169-190
  • 5[4]Bongiorno PF,al-Kasspooles M,Lee SW,achwal WJ,Moore JH,Whyte RI,Orringer MB,Beer DG.E-cadherin expression in primary and metastatic thoracic neoplasms and in Barrett's oesophagus.Br J Cancer 1995;71:166-172
  • 6[5]Swami S,Kumble S,Triadafilopoulos G.E-cadherin expression in gastroesophageal reflux disease,Barrett's esophagus,and esophageal adenocarcinoma:an immunohistochemical and immunoblot study.Am J Gastroenterol 1995;90:1808-1813
  • 7[6]Bailey T,Biddlestone L,Shepherd N,Barr H,Warner P,Jankowski J.Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence:correlation with disease progression and dedifferentiation.Am J Pathol 1998;152:135-144
  • 8[7]Takeichi M.Cadherin cell adhesion receptors as a morphogenetic regulator.Science 1991;251:1451-1455
  • 9[8]Takeichi M.Cadherins in cancer:implications for invasion and metastasis.Curr Opin Cell Biol 1993;5:806-811
  • 10[9]Birchmeier W,Behrens J.Cadherin expression in carcinomas:role in the formation of cell junctions and the prevention of invasiveness.Biochim Biophys Acta 1994;1198:11-26

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部